Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase NA 12Phase 1 8Phase 3 5Phase 1/2 3Phase 2/3 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Thoracic 1Genitourinary 1

Conditions

Prostatic Neoplasms 3Carcinoma, Hepatocellular 2Breast Neoplasms 2Stomach Neoplasms 1Pancreatic Adenocarcinoma 1Pain 1Neoplasm Metastasis 1NSCLC 1Lymphatic Metastasis 1Colorectal Neoplasms 1Castration-resistant Prostate Cancer Patients with Oligometastases 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1

Interventions

Capecitabine 16Paclitaxel 12Docetaxel 10Cyclophosphamide 10Epirubicin 8Gemcitabine 7Letrozole 6Doxorubicin 6Carboplatin 6Trastuzumab 5Vinorelbine 4Cisplatin 4pertuzumab 3exemestane 3Neoadjuvant Therapy 3Drug Therapy 3Ado-Trastuzumab Emtansine 3AC protocol 3130-nm albumin-bound paclitaxel 3apatinib 2Zoledronic Acid 2Thiotepa 2Taxes 2Tamoxifen 2Standard of Care 2Radiosurgery 2Melatonin 2Lapatinib 2Injections 2Goserelin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Breast Neoplasms × Radiosurgery × Clear all
NCT02364557 2026-05-19

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

NRG Oncology

Phase 2/3 Completed
129 enrolled 23 charts
Breast

Breast Neoplasms, Lymphatic Metastasis

NCT02759783 2019-08-21

CORE

Royal Marsden NHS Foundation Trust

Phase 2/3 Unknown
245 enrolled
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡